White Paper — Sponsored Content

How to Speed up Cell & Gene Therapy Treatments

How to Speed up Cell & Gene Therapy Treatments

How MES systems address cell and gene production problems Our white paper addresses the unique manufacturing challenges in cell and gene therapy and explains how digital solutions such as a manufacturing execution system (MES) can target these challenges. It provides guidance on how to select an MES and a case study of two CAR-T therapy companies scaling up with and without an MES. It is intended for people working in the supply chain, manufacturing operations, quality control or IT departments of cell and gene therapy companies close to obtaining therapy approval or scaling up to commercial manufacturing.

How to speed up cell & gene therapy treatments - Werum Whitepaper

 

Download White Paper


To download this white paper, complete the form below. Once submitted, you will receive a link via the email you provided to download the white paper.

Name
Company Type
Address

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.